Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amidino Beta-alanine
2. Beta-guanidine Propionic Acid
3. Beta-guanidinopropionate
4. Beta-guanidinopropionic Acid
5. Guanidine Propionate
6. Guanidinopropionic Acid
7. Pnu 10483
8. Pnu-10483
1. 353-09-3
2. 3-guanidinopropanoic Acid
3. Beta-guanidinopropionic Acid
4. Guanidinopropionic Acid
5. 3-guanidinopropanoate
6. 3-carbamimidamidopropanoic Acid
7. Beta-gpa
8. Ompenaclid
9. 3-(diaminomethylideneamino)propanoic Acid
10. N-(aminomethyl)-beta-alanine
11. Beta-guanadinopropionate
12. 3-guanidinopropanoicacid
13. Mfcd00045939
14. 3-guanidino-propionic Acid
15. Ul1984yrka
16. Chembl20489
17. .beta.-guanidinopropionic Acid
18. Chebi:15968
19. Rgx-202
20. Einecs 206-530-0
21. Unii-ul1984yrka
22. Ompenaclid [inn]
23. Guanidinepropanoicacid
24. Guanidinopropionicacid
25. Pnu-10483
26. Guanidinopropionic-acid
27. N-amidino-beta-alanin
28. B-gpa
29. Oristar Gpa
30. Guanidinoproprionic-beta
31. Guanidino Propionic Acid
32. Ss--guanidinopropionic Acid
33. N-carbamimidoyl-beta-alanine
34. Schembl33761
35. Beta-guanidinopropionic Acid.
36. Amidino .beta.-alanine
37. Gtpl4707
38. N-(aminoiminomethyl)beta-alanine
39. Rgx 202 [who-dd]
40. N-(aminoiminomethyl)-beta-alanin
41. Dtxsid40188795
42. B-alanine, N-(aminoiminomethyl)-
43. Zinc901626
44. Dl-.beta.-guanidino Propionic Acid
45. Amidino Beta-alanine [inci]
46. Amy22177
47. 3-(carbamimidoylamino)propanoic Acid
48. Bdbm50021610
49. N-[amino(imino)methyl]-beta-alanine
50. Pdsp1_000138
51. Pdsp2_000137
52. Rgx-202; 3-guanidinopropionic Acid
53. Akos006223011
54. Cs-w016544
55. Gs-6269
56. Hy-w015828
57. .beta.-alanine, N-(aminoiminomethyl)-
58. N-[amino(imino)methyl]-beta-alanine #
59. Sy066704
60. 3-[(diaminomethylidene)amino]propanoic Acid
61. Db-006453
62. Ft-0602540
63. En300-61035
64. C03065
65. H10255
66. Q5613765
67. W-106675
68. 3-guanidinopropionic Acid, Puriss., >=99.0% (nt)
69. Z959165114
| Molecular Weight | 131.13 g/mol |
|---|---|
| Molecular Formula | C4H9N3O2 |
| XLogP3 | -1.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 102 |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 128 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A RGX-202 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RGX-202, including repackagers and relabelers. The FDA regulates RGX-202 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RGX-202 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A RGX-202 supplier is an individual or a company that provides RGX-202 active pharmaceutical ingredient (API) or RGX-202 finished formulations upon request. The RGX-202 suppliers may include RGX-202 API manufacturers, exporters, distributors and traders.
RGX-202 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RGX-202 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right RGX-202 GMP manufacturer or RGX-202 GMP API supplier for your needs.
A RGX-202 CoA (Certificate of Analysis) is a formal document that attests to RGX-202's compliance with RGX-202 specifications and serves as a tool for batch-level quality control.
RGX-202 CoA mostly includes findings from lab analyses of a specific batch. For each RGX-202 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RGX-202 may be tested according to a variety of international standards, such as European Pharmacopoeia (RGX-202 EP), RGX-202 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RGX-202 USP).
LOOKING FOR A SUPPLIER?
